PolyNovo Past Earnings Performance
Past criteria checks 3/6
PolyNovo has been growing earnings at an average annual rate of 29.2%, while the Medical Equipment industry saw earnings growing at 8.3% annually. Revenues have been growing at an average rate of 37.1% per year. PolyNovo's return on equity is 7.3%, and it has net margins of 5.1%.
Key information
29.2%
Earnings growth rate
29.2%
EPS growth rate
Medical Equipment Industry Growth | 5.8% |
Revenue growth rate | 37.1% |
Return on equity | 7.3% |
Net Margin | 5.1% |
Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Is It Time To Consider Buying PolyNovo Limited (ASX:PNV)?
Oct 10PolyNovo (ASX:PNV) Is Experiencing Growth In Returns On Capital
Aug 28PolyNovo Limited's (ASX:PNV) P/S Is On The Mark
Aug 06PolyNovo Limited's (ASX:PNV) P/S Is On The Mark
May 08When Should You Buy PolyNovo Limited (ASX:PNV)?
Feb 28Why Investors Shouldn't Be Surprised By PolyNovo Limited's (ASX:PNV) P/S
Feb 02PolyNovo Limited (ASX:PNV) Shares Could Be 47% Below Their Intrinsic Value Estimate
Jan 08Health Check: How Prudently Does PolyNovo (ASX:PNV) Use Debt?
Sep 22When Should You Buy PolyNovo Limited (ASX:PNV)?
Jun 26Are Investors Undervaluing PolyNovo Limited (ASX:PNV) By 29%?
May 30Shareholders Should Be Pleased With PolyNovo Limited's (ASX:PNV) Price
Apr 18Is It Too Late To Consider Buying PolyNovo Limited (ASX:PNV)?
Mar 23Is PolyNovo Limited (ASX:PNV) Worth AU$2.6 Based On Its Intrinsic Value?
Feb 05Returns At PolyNovo (ASX:PNV) Are On The Way Up
Nov 16PolyNovo Limited's (ASX:PNV) Intrinsic Value Is Potentially 95% Above Its Share Price
Nov 01What Does PolyNovo Limited's (ASX:PNV) Share Price Indicate?
Jul 29PolyNovo (ASX:PNV) Is Looking To Continue Growing Its Returns On Capital
Jun 15Estimating The Fair Value Of PolyNovo Limited (ASX:PNV)
May 16We Think PolyNovo (ASX:PNV) Is Taking Some Risk With Its Debt
Apr 28There's Been No Shortage Of Growth Recently For PolyNovo's (ASX:PNV) Returns On Capital
Mar 07Is PolyNovo (ASX:PNV) Weighed On By Its Debt Load?
Dec 13PolyNovo Limited's (ASX:PNV) CEO Compensation Looks Acceptable To Us And Here's Why
Oct 19Is PolyNovo (ASX:PNV) Using Debt In A Risky Way?
May 08News Flash: 7 Analysts Think PolyNovo Limited (ASX:PNV) Earnings Are Under Threat
Feb 27Earnings Update: PolyNovo Limited (ASX:PNV) Just Reported And Analysts Are Trimming Their Forecasts
Feb 25Is PolyNovo Limited (ASX:PNV) Potentially Undervalued?
Feb 17Revenue & Expenses Breakdown
How PolyNovo makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 24 | 103 | 5 | 81 | 0 |
31 Mar 24 | 93 | 3 | 74 | 0 |
31 Dec 23 | 83 | 2 | 69 | 0 |
30 Sep 23 | 75 | -2 | 63 | 0 |
30 Jun 23 | 66 | -5 | 55 | 0 |
31 Mar 23 | 59 | -6 | 51 | 0 |
31 Dec 22 | 53 | -7 | 47 | 0 |
30 Sep 22 | 48 | -4 | 39 | 0 |
30 Jun 22 | 42 | -1 | 32 | 0 |
31 Mar 22 | 38 | 0 | 29 | 0 |
31 Dec 21 | 35 | 1 | 26 | 0 |
30 Sep 21 | 32 | -2 | 27 | 0 |
30 Jun 21 | 29 | -5 | 27 | 0 |
31 Mar 21 | 27 | -5 | 26 | 0 |
31 Dec 20 | 25 | -5 | 25 | 0 |
30 Sep 20 | 24 | -5 | 23 | 0 |
30 Jun 20 | 22 | -4 | 21 | 0 |
31 Mar 20 | 20 | -4 | 19 | 0 |
31 Dec 19 | 18 | -4 | 17 | 0 |
30 Sep 19 | 16 | -3 | 15 | 0 |
30 Jun 19 | 14 | -3 | 12 | 0 |
31 Mar 19 | 12 | -4 | 11 | 0 |
31 Dec 18 | 9 | -5 | 9 | 0 |
30 Sep 18 | 8 | -5 | 9 | 0 |
30 Jun 18 | 7 | -6 | 8 | 0 |
31 Mar 18 | 6 | -6 | 8 | 0 |
31 Dec 17 | 5 | -6 | 8 | 0 |
30 Sep 17 | 4 | -6 | 8 | 0 |
30 Jun 17 | 4 | -5 | 7 | 0 |
31 Mar 17 | 4 | -4 | 6 | 0 |
31 Dec 16 | 5 | -3 | 5 | 0 |
30 Sep 16 | 4 | -3 | 5 | 0 |
30 Jun 16 | 3 | -3 | 5 | 0 |
31 Mar 16 | 2 | -3 | 4 | 0 |
31 Dec 15 | 0 | -2 | 4 | 0 |
30 Sep 15 | 0 | -2 | 3 | 0 |
30 Jun 15 | 0 | -1 | 3 | 0 |
31 Mar 15 | 0 | -2 | 3 | 0 |
31 Dec 14 | 0 | -3 | 3 | 0 |
30 Sep 14 | 0 | -3 | 3 | 0 |
30 Jun 14 | 0 | -3 | 3 | 0 |
31 Mar 14 | 0 | -2 | 3 | 0 |
31 Dec 13 | 0 | -2 | 2 | 0 |
Quality Earnings: PNV has high quality earnings.
Growing Profit Margin: PNV became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: PNV has become profitable over the past 5 years, growing earnings by 29.2% per year.
Accelerating Growth: PNV has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: PNV has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (18.7%).
Return on Equity
High ROE: PNV's Return on Equity (7.3%) is considered low.